Gold Therapy in Rheumatoid Arthritis

Abstract

TREATMENT of rheumatoid arthritis with gold compounds, initiated in Europe twenty years ago, has gradually grown in favor in American medicine during the past ten years. Recently, Fraser¹ condensed the literature on chrysotherapy in this disease and noted that most observers report a favorable response in 70 to 80 per cent of patients. Short, Beckman and Bauer² found more than forty publications on gold therapy in the English literature up to 1946, almost all of which were favorable toward this type of treatment. Since these recent summaries are available, a review of the literature on this subject is not attempted . . .